Epie Boven

PROF.DR.

19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes

Kruger, D. T., Opdam, M., Sanders, J., van der Noort, V., Boven, E. & Linn, S. C., 24 Jan 2020, In : APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 128, 4, 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer

Kruger, D. T., Alexi, X., Opdam, M., Schuurman, K., Voorwerk, L., Sanders, J., van der Noort, V., Boven, E., Zwart, W. & Linn, S. C., 15 Apr 2020, In : International Journal of Cancer. 146, 8, p. 2348-2359 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

Mammatas, L. H., Venema, C. M., Schröder, C. P., de Vet, H. C. W., van Kruchten, M., Glaudemans, A. W. J. M., Yaqub, M. M., Verheul, H. M. W., Boven, E., van der Vegt, B., de Vries, E. F. J., de Vries, E. G. E., Hoekstra, O. S., Hospers, G. A. P. & der Houven van Oordt, C. W. M. V., 1 Jan 2020, In : EJNMMI Research. 10, 1, 40.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2019

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2- postmenopausal breast cancer patients treated with everolimus and exemestane

Kruger, D. T., Jansen, M. P. H. M., Konings, I. R. H. M., Dercksen, W. M., Jager, A., Oulad Hadj, J., Sleijfer, S., Martens, J. W. M. & Boven, E., 16 Dec 2019, In : Molecular oncology.

Research output: Contribution to journalArticleAcademicpeer-review

2018

A genetic polymorphism in ctla-4 is associated with overall survival in sunitinib-treated patients with clear cell metastatic renal cell carcinoma

Liu, X., Swen, J. J., Diekstra, M. H. M., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H. J., Vermeulen, S. H., Oosterwijk, E., Junker, K., Roessler, M., Alexiusdottir, K., Sverrisdottir, A., Radu, M. T., Ambert, V., Eisen, T., Warren, A., Rodríguez-Antona, C., García-Donas, J., Bohringer, S. & 4 others, Koudijs, K. K. M., Kiemeney, L. A. L. M., Rini, B. I. & Guchelaar, H-J., 2018, In : Clinical Cancer Research. 24, 10, p. 2350-2356

Research output: Contribution to journalArticleAcademicpeer-review

Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

Kruger, D. T., Beelen, K. J., Opdam, M., Sanders, J., van der Noort, V., Boven, E. & Linn, S. C., 2018, In : British Journal of Cancer. 119, 7, p. 832-839 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer

Lam, S. W., van der Noort, V., van der Straaten, T., Honkoop, A. H., Peters, G. J., Guchelaar, H. J. & Boven, E., 1 Feb 2018, In : Pharmacological Research. 128, p. 122-129 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2017

Androgen and estrogen receptor imaging in metastatic breast cancer patients as a surrogate for tissue biopsies

Venema, C. M., Mammatas, L. H., Schröder, C. P., van Kruchten, M., Apollonio, G., Glaudemans, A. W. J. M., Bongaerts, A. H. H., Hoekstra, O. S., Verheul, H. M. W., Boven, E., van der Vegt, B., de Vries, E. F., de Vries, E. G. E., Boellaard, R., Menke-van der Houven van Oordt, C. W. & Hospers, G. A., 1 Dec 2017, In : Journal of Nuclear Medicine. 58, 12, p. 1906-1912 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

2016

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice

Timmers, L., Boons, C. C. L. M., Mangnus, D., Van de Ven, P. M., Van den Berg, P. H., Beeker, A., Swart, E. L., Honeywell, R. J., Peters, G. J., Boven, E. & Hugtenburg, J. G., 21 Sep 2016, In : Frontiers in Pharmacology. 7

Research output: Contribution to journalArticleAcademicpeer-review

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Wentink, M. Q., Broxterman, H. J., Lam, S. W., Boven, E., Walraven, M., Griffioen, A. W., Pili, R., van der Vliet, H. J., de Gruijl, T. D. & Verheul, H. M. W., 11 Oct 2016, In : British Journal of Cancer. 115, 8, p. 940-948

Research output: Contribution to journalArticleAcademicpeer-review

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy

Lam, S. W., Nota, N. M., Jager, A., Bos, M. M. E. M., van den Bosch, J., van der Velden, A. M. T., Portielje, J. E. A., Honkoop, A. H., van Tinteren, H. & Boven, E., 1 Apr 2016, In : Clinical Cancer Research. 22, 7, p. 1611-1620

Research output: Contribution to journalArticleAcademicpeer-review

ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN IL8 AND IL13 WITH SUNITINIB-INDUCED TOXICITY IN PATIENTS WITHMETASTATIC RENAL CELL CARCINOMA.

Liu, X., Diekstra, M. H., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B. I. & Guchelaar, H., Feb 2016, In : Clinical Pharmacology & Therapeutics. 99, p. S6-S7

Research output: Contribution to journalArticleAcademicpeer-review

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study

Menning, S., de Ruiter, M. B., Kieffer, J. M., Agelink van Rentergem, J., Veltman, D. J., Fruijtier, A., Oldenburg, H. S. A., Boven, E., van der Meij, S., Lustig, V., Bos, M. E. M., Boogerd, W., Reneman, L. & Schagen, S. B., 2016, In : Journal of Pain and Symptom Management. 52, 4, p. 560-569.e1

Research output: Contribution to journalArticleAcademicpeer-review

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients

Lam, S. W., Frederiks, C. N., van der Straaten, T., Honkoop, A. H., Guchelaar, H-J. & Boven, E., 22 Nov 2016, In : British Journal of Cancer. 115, 11, p. 1335-1342

Research output: Contribution to journalArticleAcademicpeer-review

Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer

Warmoes, M., Lam, S. W., van der Groep, P., Jaspers, J. E., Smolders, Y. H. C. M., de Boer, L., Pham, T. V., Piersma, S. R., Rottenberg, S., Boven, E., Jonkers, J., van Diest, P. J. & Jimenez, C. R., 27 Sep 2016, In : Oncotarget. 7, 39, p. 63537-63548

Research output: Contribution to journalArticleAcademicpeer-review

The role of pharmacogenetics in capecitabine efficacy and toxicity

Lam, S. W., Guchelaar, H. J. & Boven, E., Nov 2016, In : Cancer Treatment Reviews. 50, p. 9-22

Research output: Contribution to journalArticleAcademicpeer-review

2015

Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer

Timmers, L., Boons, C. C. L. M., ten Hove, J. E., Smit, E. F., van de Ven, P. M., Aerts, J. G., Swart, E. L., Boven, E. & Hugtenburg, J. G., 2015, In : Journal of Cancer Research and Clinical Oncology. 141, 8, p. 1481-1491

Research output: Contribution to journalArticleAcademicpeer-review

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

Diekstra, M. H. M., Liu, X. Y., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H. J., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B. I. & Guchelaar, H. J., 2015, In : European Journal of Clinical Pharmacology. 71, 12, p. 1477-1484

Research output: Contribution to journalArticleAcademicpeer-review

CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma

Diekstra, M. H. M., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H. J., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B. I. & Guchelaar, H. J., 2015, In : European Urology. 68, 4, p. 621-629

Research output: Contribution to journalArticleAcademicpeer-review

Effect of Low-Intensity Physical Activity and Moderate-to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial

van Waart, H., Stuiver, M. M., van Harten, W. H., Geleijn, E., Kieffer, J. M., Buffart, L. M., de Maaker-Berkhof, M., Boven, E., Schrama, J., Geenen, M. M., Terwogt, J. M. M., Van Bochove, A., Lustig, V., van den Heiligenberg, S. M., Smorenburg, C. H., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S. & Aaronson, N. K., 2015, In : Journal of Clinical Oncology. 33, 17, p. 1918-1927

Research output: Contribution to journalArticleAcademicpeer-review

Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review

Frederiks, C. N., Lam, S. W., Guchelaar, H. J. & Boven, E., 2015, In : Cancer Treatment Reviews. 41, 10, p. 935-950

Research output: Contribution to journalArticleAcademicpeer-review

2014

Adherence and patients' experiences with the use of oral anticancer agents

Timmers, L., Boons, C. C. L. M., Kropff, F., van de Ven, P. M., Swart, E. L., Smit, E. F., Zweegman, S., Kroep, J. R., Timmer-Bonte, J. N. H., Boven, E. & Hugtenburg, J. G., 2014, In : Acta Oncologica. 53, 2, p. 259-267

Research output: Contribution to journalArticleAcademicpeer-review

Biomarker Study Everolimus, een studie van de Borstkanker Onderzoek Groep Nederland

Kruger, D. T., Beelen, S., Sleijfer, M. P. H. M., Jansen, C. R., Jimenez, C. R., Linn, S. C. & Boven, E., 2014, In : Kanker Breed. 6, 2

Research output: Contribution to journalArticlePopular

Breast cancer classification by proteomic technologies: Current state of knowledge

Lam, S. W., Jimenez, C. R. & Boven, E., 2014, In : Cancer Treatment Reviews. 40, 1, p. 129-138

Research output: Contribution to journalArticleAcademicpeer-review

Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling

de Wit, M., Kant, H., Piersma, S. R., Pham, T. V., Mongera, S., van Berkel, M. P. A., Boven, E., Ponten, F., Meijer, G. A., Jimenez, C. R. & Fijneman, R. J. A., 2014, In : Journal of Proteomics. 99, p. 26-39

Research output: Contribution to journalArticleAcademicpeer-review

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Lam, S. W., de Groot, S. M., Honkoop, A. H., Jager, A., ten Tije, A. J., Bos, M. M. E. M., Linn, S. C., Bosch, J., Kroep, J. R., Braun, J. J., van Tinteren, H. & Boven, E., 2014, In : European Journal of Cancer. 50, 18, p. 3077-3088

Research output: Contribution to journalArticleAcademicpeer-review

2013

Proteomics of Genetically Engineered Mouse Mammary Tumors Identifies Fatty Acid Metabolism Members as Potential Predictive Markers for Cisplatin Resistance

Warmoes, M. O., Jaspers, J. E., Xu, G. T., Sampadi, B. K., Pham, T. V., Knol, J. C., Piersma, S. R., Boven, E., Jonkers, J., Rottenberg, S. & Jimenez, C. R., 2013, In : Molecular and Cellular Proteomics. 12, 5, p. 1319-1334

Research output: Contribution to journalArticleAcademicpeer-review

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study

Hamaker, M. E., Seynaeve, C., Nortier, J. W. R., Wymenga, M., Maartense, E., Boven, E., van Leeuwen-Stok, A. E., Rooij, S. E., van Munster, B. C. & Smorenburg, C. H., 2013, In : Breast. 22, 4, p. 556-559

Research output: Contribution to journalArticleAcademicpeer-review

2012

Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-Induced Menopausal Symptoms in Patients With Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial

Duijts, S. F. A., van Beurden, M., Oldenburg, H. S., Hunter, M. S., Kieffer, J. M., Stuiver, M. M., Gerritsma, MA., Menke-Pluymers, M. B. E., Plaisier, P. W., Rijna, H., Cardozo, A. M. F. L., Timmers, G., van der Meij, S., van der Veen, H., Bijker, N., de Widt-Levert, L. M., Geenen, M. M., Heuff, G., van Dulken, E. J., Boven, E. & 1 others, Aaronson, N. K., 2012, In : Journal of Clinical Oncology. 30, 33, p. 4124-4133

Research output: Contribution to journalArticleAcademicpeer-review

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., Lavini, C., Linn, S. C., Boven, E., van Dam, F. S. A. M. & Schagen, S. B., 2012, In : Human Brain Mapping. 33, 12, p. 2971-2983

Research output: Contribution to journalArticleAcademicpeer-review

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Kaye, S., Aamdal, S., Jones, R., Freyer, G., Pujade-Lauraine, E., de Vries, E. G. E., Barriuso, J., Sandhu, S., Tan, D. S. W., Hartog, V., Kuenen, B., Ruijter, R., Kristensen, G. B., Nyakas, M., Barrett, S., Burke, W., Pietersma, D., Stuart, M., Emeribe, U. & Boven, E., 2012, In : British Journal of Cancer. 106, 11, p. 1728-1734

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
61 Downloads (Pure)

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

Eechoute, K., van der Veldt, A. A. M., Oosting, S., Kappers, M. H. W., Wessels, J. A. M., Gelderblom, H., Guchelaar, H. J., Reyners, A. K. L., van Herpen, C. M. L., Haanen, J. B., Mathijssen, R. H. J. & Boven, E., 2012, In : Clinical Pharmacology & Therapeutics. 92, 4, p. 503-510

Research output: Contribution to journalArticleAcademicpeer-review

Proteomics of Mouse BRCA1-deficient Mammary Tumors Identifies DNA Repair Proteins with Potential Diagnostic and Prognostic Value in Human Breast Cancer

Warmoes, M. O., Jaspers, J. E., Pham, T. V., Piersma, S. R., Oudgenoeg, G., Massink, M. P. G., Waisfisz, Q., Rottenberg, S., Boven, E., Jonkers, J. & Jimenez, C. R., 2012, In : Molecular and Cellular Proteomics. 11, 7, M111.013334.

Research output: Contribution to journalArticleAcademicpeer-review

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation

Ruiterkamp, J., Voogd, A. C., Tjan-Heijnen, V. C. G., Bosscha, K., van der Linden, Y. M., Rutgers, E. J. T., Boven, E., van der Sangen, M. J. C. & Ernst, M. F., 2012, In : BMC Surgery. 12, 5.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
55 Downloads (Pure)

Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer

van der Veldt, A. A. M., Vroling, L., de Haas, R. R., Koolwijk, P., van den Eertwegh, A. J. M., Haanen, J. B. A. G., van Hinsbergh, V. W. M., Broxterman, H. J. & Boven, E., 2012, In : International Journal of Cancer. 131, 4, p. E484-E493

Research output: Contribution to journalArticleAcademicpeer-review

The use of capecitabine in daily practice: a study on adherence and patients' experiences

Timmers, L., Swart, E. L., Boons, C. C. L. M., Mangnus, D., van de Ven, P. M., Peters, G. J., Boven, E. & Hugtenburg, J. G., 2012, In : Patient Preference and Adherence. 6, p. 741-748

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
59 Downloads (Pure)

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008

Timmers, L., Beckeringh, J. J., van Herk-Sukel, M. P. P., Boven, E. & Hugtenburg, J. G., 2012, In : Pharmacoepidemiology and Drug Safety. 21, 10, p. 1036-1044

Research output: Contribution to journalArticleAcademicpeer-review

Validation of Serum Amyloid alpha as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients

Vermaat, J. S., Gerritse, F. L., van der Veldt, A. A., Roessingh, W. M., Niers, T. M., Oosting, S. F., Sleijfer, S., Roodhart, J. M., Beijnen, J. H., Schellens, J. H., Gietema, J. A., Boven, E., Richel, D. J., Haanen, J. B. & Voest, E. E., 2012, In : European Urology. 62, 4, p. 685-695

Research output: Contribution to journalArticleAcademicpeer-review

2011

Cerebral Hyporesponsiveness and Cognitive Impairment 10 Years After Chemotherapy for Breast Cancer

de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S. A. M., Nederveen, A. J., Boven, E. & Schagen, S. B., 2011, In : Human Brain Mapping. 32, 8, p. 1206-1219

Research output: Contribution to journalArticleAcademicpeer-review

Cetuximab of panitumumab voor gemetastaseerd colorectaalcarcinoom?

Boven, E., 2011, In : Nederlands Tijdschrift voor Oncologie. 8, p. 27-33

Research output: Contribution to journalArticleProfessional

Cytofys, behoud van kracht en uithoudingsvermogen tijdens chemotherapie

Geleijn, E., Smeets, C., Vrijman, M., Kron, D., Boven, E. & Stuiver, M., 2011, In : Nederlands Tijdschrift voor Oncologie. 8, p. 80-86

Research output: Contribution to journalArticleProfessional

Nieuwe, gerichte behandelingen voor de patiënt met kanker

Boven, E., 2011, In : Huisarts en Wetenschap. 54, p. 266-271

Research output: Contribution to journalArticleProfessional

Phase I trial of SU14813 in patients with advanced solid malignancies

Fiedler, W., Giaccone, G., Lasch, P., van der Horst, I., Brega, N., Courtney, R., Abbattista, A., Shalinsky, D. R., Bokemeyer, C. & Boven, E., 2011, In : Annals of Oncology. 22, 1, p. 195-201

Research output: Contribution to journalArticleAcademicpeer-review

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method

van Leeuwen, R. W. F., Swart, E. L., Boven, E., Boom, F. A., Schuitenmaker, M. G. & Hugtenburg, J. G., 2011, In : Annals of Oncology. 22, 10, p. 2334-2341

Research output: Contribution to journalArticleAcademicpeer-review

Prognostic Factors for Survival in Patients With Recurrence of Muscle Invasive Bladder Cancer After Treatment With Curative Intent

van der Ploeg, M., Kums, A. C., Aben, K. K., van Lin, E. N., Smits, G., Vergunst, H., Viddeleer, A. C., Geboers, A. D., van Berkel, H., Boven, E., Kiemeney, L. A. L. M. & Witjes, F., 2011, In : Clinical Genitourinary Cancer. 9, 1, p. 14-21

Research output: Contribution to journalArticleAcademicpeer-review

The use of erlotinib in daily practice: a study on adherence and patients' experiences

Timmers, L., Boons, C. C. L. M., Mangnus, D., Moes, D. J. A. R., Swart, E. L., Boven, E., Smit, E. F. & Hugtenburg, J. G., 2011, In : BMC Cancer. 11, 284.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
58 Downloads (Pure)
2010

A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

Boven, E., Massard, C., Armand, J. P., Tillier, C., Hartog, V., Brega, N. M., Countouriotis, A. M., Ruiz-Garcia, A. & Soria, J. C., 2010, In : British Journal of Cancer. 103, 7, p. 993-1000

Research output: Contribution to journalArticleAcademicpeer-review

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

van der Veldt, A. A. M., Meijerink, M. R., van den Eertwegh, A. J. M., Haanen, J. B. A. G. & Boven, E., 2010, In : British Journal of Cancer. 102, 5, p. 803-809

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
77 Downloads (Pure)

De behandeling van het gemetastaseerde mammacarcinoom

Boven, E., 2010, In : Farmacotherapie-Online. p. 1-32

Research output: Contribution to journalArticleProfessional